10x Genomics, Inc. financial data

Symbol
TXG on Nasdaq
Location
Pleasanton, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 13 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 495% % -2.3%
Quick Ratio 50% % -34%
Debt-to-equity 29% % 0.39%
Return On Equity -5.7% % 78%
Return On Assets -4.4% % 78%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 127,691,329 shares 4.4%
Entity Public Float $1,300,000,000 USD -28%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 124,749,885 shares 3.6%
Weighted Average Number of Shares Outstanding, Diluted 124,749,885 shares 3.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $642,823,000 USD 5.2%
Cost of Revenue $198,942,000 USD 1.3%
Operating Income (Loss) $60,985,000 USD 69%
Nonoperating Income (Expense) $21,078,000 USD 25%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $39,907,000 USD 78%
Income Tax Expense (Benefit) $3,637,000 USD -26%
Net Income (Loss) Attributable to Parent $43,544,000 USD 76%
Earnings Per Share, Basic -0.35 USD/shares 77%
Earnings Per Share, Diluted -0.35 USD/shares 77%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $344,067,000 USD -4.2%
Accounts Receivable, after Allowance for Credit Loss, Current $47,013,000 USD -46%
Inventory, Net $56,341,000 USD -32%
Assets, Current $684,451,000 USD 17%
Property, Plant and Equipment, Net $226,711,000 USD -10%
Operating Lease, Right-of-Use Asset $60,450,000 USD 5.5%
Intangible Assets, Net (Excluding Goodwill) $62,329,000 USD 298%
Goodwill $4,511,000 USD 0%
Other Assets, Noncurrent $2,913,000 USD -29%
Assets $1,041,365,000 USD 13%
Accounts Payable, Current $12,733,000 USD -1.4%
Employee-related Liabilities, Current $42,500,000 USD 26%
Contract with Customer, Liability, Current $23,902,000 USD 16%
Liabilities, Current $153,454,000 USD 30%
Contract with Customer, Liability, Noncurrent $10,501,000 USD -16%
Operating Lease, Liability, Noncurrent $73,376,000 USD 0.07%
Other Liabilities, Noncurrent $6,471,000 USD 29%
Liabilities $245,039,000 USD 18%
Accumulated Other Comprehensive Income (Loss), Net of Tax $225,000 USD
Retained Earnings (Accumulated Deficit) $1,510,591,000 USD -3%
Stockholders' Equity Attributable to Parent $796,326,000 USD 12%
Liabilities and Equity $1,041,365,000 USD 13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $34,351,000 USD
Net Cash Provided by (Used in) Financing Activities $422,000 USD -74%
Net Cash Provided by (Used in) Investing Activities $1,893,000 USD -118%
Common Stock, Shares Authorized 1,100,000,000 shares 0%
Common Stock, Shares, Issued 127,691,329 shares 4.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $32,994,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $473,966,000 USD 38%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $490,154,000 USD 2.2%
Deferred Tax Assets, Gross $505,840,000 USD 1.9%
Operating Lease, Liability $84,361,000 USD 2.1%
Payments to Acquire Property, Plant, and Equipment $1,893,000 USD -35%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $42,826,000 USD 77%
Lessee, Operating Lease, Liability, to be Paid $103,019,000 USD 1.8%
Property, Plant and Equipment, Gross $380,175,000 USD 1.2%
Operating Lease, Liability, Current $10,985,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid, Year Two $16,805,000 USD 9.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $15,630,000 USD 13%
Operating Lease, Weighted Average Discount Rate, Percent 0.059 pure 1.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18,658,000 USD 0.45%
Lessee, Operating Lease, Liability, to be Paid, Year Three $16,394,000 USD 5.3%
Deferred Tax Assets, Operating Loss Carryforwards $202,704,000 USD 25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Unrecognized Tax Benefits $55,490,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,800,000 USD -6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $8,022,000 USD -13%
Deferred Tax Assets, Net of Valuation Allowance $15,686,000 USD -6.2%
Share-based Payment Arrangement, Expense $108,804,000 USD -23%
Interest Expense $15,000 USD -96%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%